Superion Clinical Research

VertiFlex® has compiled the largest, most rigorous body of device clinical evidence related to relieving the pain of moderate lumbar spinal stenosis (LSS). 470 patients have been enrolled in a Superion U.S. IDE trial, as well as approximately 200 additional patients in 3 Superion studies outside the United States. The data from all studies suggest significant relief from the symptoms of spinal stenosis is achievable, along with very high patient satisfaction with the surgery.

The FDA approved the device in May 2015 for U.S. distribution.

© 2016 VertiFlex Inc.

Superion Interspinous Spacer

Superion® Interspinous Spacer